ALS LIMITED — Capital/Financing Update 2019

Apr 28, 2019

==> picture [180 x 69] intentionally omitted <==

asx/media release

29 April 2019

ALS divests China Environmental business

ALS Limited (ASX Code: ALQ) today announced the completion of the sale of its environmental and analytical testing business in China for USD$57.3m and adjusted net cash to SUEZ, a world leader in smart and sustainable resource management.

ALS Life Sciences China provides environmental and analytical testing services in 3 laboratories across Shanghai, Beijing and Guangzhou.

Commenting on the transaction, ALS Managing Director and CEO Raj Naran congratulated SUEZ on the acquisition stating it was “a natural acquirer of the business given its growing presence and commitment to investment in the region and adjacent technologies and sectors.”

Mr Naran added “Given the relatively small size of the business, an increasingly fragmented market, and the absence of a platform for vertical integration, ALS believes its capital will be more efficiently allocated in the longer term if invested to align with our dedicated strategy to expand into the Food and Pharmaceutical sectors into other geographies in Asia, Europe, and North and South America”.

Further information:

Raj Naran Managing Director ALS Limited +61 (7) 3367 7900

About ALS Limited

ALS is a global Testing, Inspection & Certification business. The company's strategy is to broaden its exposure into new sectors and geographies where it can take a leadership position.